In Vitro Fertilization Market Size Worth $37.4 Billion By 2030

April 2022 | Report Format: Electronic (PDF)

In Vitro Fertilization Market Growth & Trends

The global in vitro fertilization market size is expected to reach USD 37.4 billion by 2030, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 5.72% from 2023 to 2030. The market is driven by the continuous efforts of the market players, government initiatives to make available better reimbursement policies, and an increase in the incidence of infertility due to lifestyle changes. The expansion of fertility procedures such as ICSI for treating infertility is expected to positively impact market growth in the near future.

Moreover, the availability of genomic testing facilities that enable the prevention of the transfer of genetic disorders during In Vitro Fertilization (IVF) is further expected to drive the IVF market. The insurance providers are providing coverage for IVF procedures owing to an increase in the number of IVF treatments. This has led to competitive pricing and has moderated the IVF treatment costs as the procedure has been a successfully practiced technology, driving the market with more treatment automation and standardization.

A decline in the Total Fertility Rate (TFR) is a result of factors such as a behavioral shift in society. These factors include a shift from rural to urban societies, the increased age of the first birth, postponement of marriage, an increasing number of women employees, and lower marriage rates. In March 2020, in-person fertility treatments in U.S. and Canada were suspended due to COVID-19 by the American Society of Reproductive Medicine and Canadian Fertility and Andrology Society. However, treatment is resuming in many countries with the ease of COVID-19 restrictions. The research findings published by the Obstetrics and Gynecology journal, in January 2022 reported COVID-19 vaccines won't harm IVF outcomes. This is expected to prove significant in promoting the uptake of IVF in eligible vaccinated individuals.

key Request a free sample copy or view the report summary: In Vitro Fertilization Market Report

In Vitro Fertilization Market Report Highlights

  • The culture media segment dominated the market in terms of revenue in 2022. A number of research activities are being undertaken to improve the efficiency of cultural media. For instance, Vitrolife showcased its research on SpermFreeze solution at the American Society for Reproductive Medicine (ASRM) that established the effectiveness of its solution for sperm recovery and sperm-hyaluronic acid-binding

  • Europe dominated the market for procedures and instruments in 2022. Adoption of advanced technologies such as time-lapse microscopy by the clinics, availability of affordable treatment, and adherence to medical standards contribute to its market dominance

  • In APAC, the market is expected to witness increased demand for IVF owing to fertility tourism and the availability of funding for the treatment. In Japan, eligible couples can apply for co-funding for a maximum of three cycles with USD 1,920 for each cycle

  • The developing countries in the Asia Pacific region are undertaking legal reforms to promote treatment adoption in the region. For instance, in February 2020, the Government of India approved a bill for the regulation of clinics offering reproduction assistance services, including IVF, artificial insemination, and surrogacy

  • In January 2020, Merck received Marketing Authorization (MA) from the European Commission (EC) for its recombinant human follicle-stimulating hormone, GONAL-f (follitropin alfa) 150 IU pen 

In Vitro Fertilization Market Segmentation 

Grand View Research has segmented the global in vitro fertilization market based on instrument, procedure type, end-use, and region:

In Vitro Fertilization Instrument Outlook (Revenue, USD Million, 2017 - 2030)

  • Disposable Devices

  • Culture Media

  • Capital Equipment

In Vitro Fertilization Procedure Type Outlook (Revenue, USD Million, 2017 - 2030)

  • Fresh Donor

  • Frozen Donor

  • Fresh Non-donor

  • Frozen Non-donor

In Vitro Fertilization End-use Outlook (Revenue, USD Million, 2017 - 2030)

  • Fertility Clinics

  • Hospitals & Other Setting

In Vitro Fertilization Regional Outlook (Revenue, USD Million, 2017 - 2030)

  • North America

    • U.S.

    • Canada

  • Europe

    • France

    • Germany

    • Italy

    • Spain

    • U.K.

    • Belgium

    • Netherlands

    • Switzerland

  • Asia Pacific

    • Japan

    • China

    • India

    • Australia

    • South Korea

  • Latin America

    • Brazil

    • Mexico

    • Argentina

  • Middle East & Africa (MEA)

    • South Africa

    • Saudi Arabia

    • UAE

List of Key Players in In Vitro Fertilization Market

  • OvaScience

  • EMD Serono Inc.

  • Vitrolife AB

  • Irvine Scientific

  • Cook Medical Inc.

  • Cooper Surgical Inc.

  • GeneaBiomedx

  • Thermo Fisher Scientific Inc.

  • Progyny, Inc.

  • Boston IVF

gvr icn


gvr icn

This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.

gvr icn


We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.

Contact us now to get our best pricing.